πŸ‡ΊπŸ‡Έ FDA
Patent

US 11873300

Crystalline forms of CFTR modulators

granted A61PA61P11/00

Quick answer

US patent 11873300 (Crystalline forms of CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P11/00